Tsubota Laboratory Incorporated
public_traded
Tsubota Laboratory Incorporated is publicly traded on JPX under ticker 4890.T.
Tsubota Laboratory Incorporated engages in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia. The company was incorporated in 2012 and is based in Tokyo, Japan.